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It has been  known for over 30 yr that  gram-negative bacteria enhance immune 
responses to vaccines in man (1) and that the active adjuvant component is cell wall 
lipopolysaecharide  (LPS) 1  (2).  However,  the  precise  mechanism  by  which  LPS 
mediates its adjuvant effect has not yet been resolved. 
Because LPS is a  potent B-cell  mitogen, a polyclonal B-cell  activator, and acts as 
a  T-independent  antigen,  several  investigators  have  suggested  that  the  adjuvant 
properties of LPS are most easily ascribed to a direct effect of LPS on the B cells (3- 
6). Because LPS reverses tolerance to immunity, even in the presence of T-suppressor 
cells,  this has been taken as further proof that LPS enhances B-cell  responses (5,  7). 
LPS  can  also  bypass  the  requirement  for  T-helper  cells  by  facilitating  immune 
responses in mice given haptenated, homologous erythrocytes (8, 9). Finally, the lack 
of tolerance reversal to human gamma globulin by LPS in C3H/HeJ mice (whose B 
cells  are  unresponsive  to  LPS)  has  been  taken  as  evidence  that  potentiation  is 
occurring at the level of the B cell (3,  10, 11). 
Alternatively, a  number of studies have suggested that the adjuvant properties of 
LPS are best explained through activation of T cells (12-17). Allison and Davies (12), 
utilizing both thymectomized mice and  mice treated with anti-lymphocyte serum, 
demonstrated that LPS adjuvanticity required normal T-cell populations. In a series 
of experiments,  Katz  and  coworkers  (13-15)  also  provided  evidence  for  a  T-cell 
requirement during LPS-mediated augmentation of antibody responses. In the first 
experiments,  removal  of T  cells  from  antigen-primed  spleen  cells  before  adoptive 
transfer  and  subsequent  challenge  abrogated  the  capacity  of LPS  to  mediate  its 
adjuvant effect (13). Subsequent studies (14,  15) provided evidence that the adjuvant 
effect  of LPS  on  hapten-specific  IgM,  IgG,  and  IgE  plaque-forming  cell  (PFC) 
responses was exerted on carrier primed, T-helper cell activity. More recent evidence 
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i Abbreviations  used  in  this paper:  Bu-LPS,  LPS  prepared  by butanol-water extraction;  FCS,  fetal calf 
serum;  LAF,  lymphocyte-activating factor;  LAP,  lipid  A-associated  protein;  LPS,  lipopolysaccharide; 
MLR, mixed lymphocyte reaction; MO, macrophage; nu/nu, athymic nude mice; nu/+,  normal litter- 
mates  of  athymic  nude  mice;  PFC,  plaque-forming  cells;  Ph-LPS,  LPS  prepared  by  phenol-water 
extraction; SRC, sheep erythroeytes; TNF, tumor necrosis  factor; TNP, trinitrophenyl. 
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suggests that a subpopulation ofT cells regulates B-cell responses to LPS and eventual 
immunoglobulin production  (16,  17). 
Because  the  macrophage  (MO)  is  an  important  accessory  cell  in  the  immune 
response,  enhancement  of its  activity by LPS could  also  account  for adjuvanticity. 
Allison and  coworkers  (18,  19)  found that  administration  of antigen  with  MO  and 
LPS greatly enhanced immune responses.  More recently, it has been found that LPS 
causes the release from MO of lymphocyte-activating factor (LAF)  (20).  Subsequent 
biochemical  characterization  studies  have shown  that  highly purified  LAF does,  in 
fact,  enhance  the  antibody  response  (21,  22),  although  LAF-containing supernates 
augment antibody production only in the presence of T  cells (23). Finally, Hoffmann 
and  coworkers  (9)  have  shown  that  administration  of  LPS  to  mice  induces  the 
production  of a  serum  factor  (presumably  MO  derived)  that  potentiates  antibody 
responses of C3H/HeJ  (LPS nonresponsive)  B cells. 
Given this continuing controversy over the precise lymphoid cell types affected by 
LPS, we have  studied  potentiation  of immune  responses  to particulate  antigens  in 
vitro as a  correlate of LPS adjuvanticity.  Spleen cells from either  LPS responsive or 
nonresponsive  mice  were  used  as  the  source  of T  and  B  lymphocytes  and  MO. 
Subsequent  mixing of these different cell populations  in culture allowed us to assess 
the importance of each cell type in LPS potentiation of immune responses. Our results 
clearly  indicate  that  both  T  lymphocytes  and  MtZI  must  be  derived  from  LPS- 
responsive mice to obtain  an LPS-induced enhancement  of the immune response to 
particulate  antigens. 
Materials  and Methods 
Animals.  C3H/HeJ and C57BL/10Sn were obtained from The Jackson Laboratories (Bar 
Harbor,  Maine).  C3H/HeN,  C3H/HeN nude  (nu/nu)  and  normal  littermates  (nu/+)  (the 
progeny of eight cycles of crossing into the C3H/HeN strain), and C57BL/10ScN nu/nu and 
nu/+  (the progeny of nine cycles of crossing into the C57BL/10SEN strain) mice were provided 
by the Division of Research Resources (National Institutes of Health, Bethesda, Maryland). 7- 
to 12-wk-old mice were used for all studies. 
Endotoxin.  Escherichia coli K235 LPS prepared by a phenol-water extraction (Ph) procedure 
(24) or by a butanol-water extraction (Bu) method (25) was employed in these studies. 
Culture  Methods.  Mouse spleens  were aseptically removed and single cell suspensions were 
prepared by passage through a sterile  screen (60 mesh).  Cells were washed and cultured by the 
method of Mishell and Dutton (26) with modification. Specifically, cultures contaiing 5 X  10  ~ 
spleen cells in 0.5 ml complete medium (26) in 16-ram multiwell Linbro trays (Linbro Chemical 
Co.,  Hamden,  Conn.)  were  immunized  with  either  2  X  106  sheep  erythrocytes  (SRC)  or 
trinitrophenyl conjugated SRC  2 (McGhee et al.). Briefly, 20 mg of 2,4,6-trinitrobenzene sulfonic 
acid (Pierce Chemical Co., Rockford, Ill.)  in 2 ml cacodylate buffer, pH 6.9 was added to 0.5 
ml packed SRC and reacted for 30 min at room temperature, The reaction mixture was stopped 
with excess glycylglycine buffer and the cells were washed extensively with medium. After the 
addition  of either  Ph-LPS  or  Bu-LPS,  cultures  were  incubated  (37°C)  with  rocking  in  a 
humidified chamber containing 7% 02,  10% CO2, and 83% N2. The nutritional mixture (0.05 
ml)  described by Mishell  and  Dutton  (26) was added  daily to each culture.  Cultures  were 
assayed for either anti-SRC or anti-TNP PFC on day 5. 
Similar culture methods were employed in cell mixing experiments. In these studies, various 
combinations of  spleen cell subpopulations (described below) of  either nonadherent lymphocytes 
(3  X  106/cuhure), T cells (1  X  106/cuhure), B cells (1  X  106/culture), and/or a monolayer of 
adherent cells were cultured in 0.5 ml complete medium (Results). 
2 McGhee, J. R., S. M. Michalek, R. N. Moore, S. E. Mergenhagen, and D. L. Rosenstreich. 1979.  J. 
Immunol. In press. J.  R.  McGHEE  ET AL.  795 
Purification of Splenic Macrophages.  MO-rich populations were prepared from spleen cells by 
an adherence technique. The concentration of single spleen cell suspensions was adjusted to 107 
spleen cells/ml. Subsequent to centrifugation, the pellet of cells was irradiated with 1,000 rads, 
the su6pernate  removed, and  the cells resuspended in medium. 0.5  ml aliquots (containing 5 
×  10  cells)  were  added  to  individual wells and  incubated  at  room  temperature  for  2  h. 
Nonadherent cells were removed by repeated addition and removal of medium (three to four 
times). The remaining adherent  monolayer of cells served as the source of MO in all of the 
experiments reported herein. 
Purification of Splenic  T  and  B  Lymphocytes.  MO-depleted  spleen  cell  preparations  were 
prepared  as  previously described  (27)  by consecutive passage  through  two  Sephadex G-10 
columns. (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.). The effluent 
cells were used as the source of nonadherent lymphocytes. These preparations did not support 
immune responses to particulate antigen (Results). 
Purified individual T  and B  populations were prepared from spleen cell suspensions. The 
spleen cells were first treated with ammonium chloride erythrocyte-lysing  solution-lysing buffer 
(Media Unit, National Institutes of Health, Bethesda, Md.) for 10 min at 4°C and subsequently 
washed  with  medium  supplemented  with  2%  fetal  calf serum  (FCS).  The  resultant  cell 
preparations were  passed  through  7-ml  glass wool columns  to  remove  adherent  cells. The 
nonadherent cells were eluted with medium supplemented with 2% FCS (at room temperature) 
and subsequently applied to a nylon wool column according to the method of  Julius et al. (28). 
T  cells were eluted from this column with warm medium. Splenic B cells were prepared by 
compression of the nylon wool using the method of Handwerger and Schwartz (29).  In some 
experiments, primed T  cells were prepared by using spleens of mice which had been intrave- 
nously injected  1 wk before with SRC  (0.1 ml of 0.01%  suspension, reference 30).  The T-cell 
preparations were further treated to remove residual B cells by using anti-mouse immunoglob- 
ulin serum (Meloy Laboratories Inc., Springfield, Va.) and complement as previously described 
(31).  In  certain experiments B-cell preparations were  incubated  with  anti-theta serum  and 
complement to remove residual T  cells (31). 
PFC Assay.  After a  5-d incubation, nonadherent  cells were removed  from  culture wells, 
washed, and resuspended to an appropriate volume for assay. Cultures in triplicate were tested 
for anti-SRC or anti-TNP  PFC  using the slide modification  (26)  of the Jerne  and  Nordin 
hemolytic plaque assay. For the TNP assay, lightly conjugated, TNP-SRC were prepared by 
the method of Rittenberg and Pratt (32). 
Mixed  Lymphocyte Reaction  (MLR)  Assay.  The  MLR  assay  was  performed  as  described 
previously (33). Single spleen cell suspensions were prepared as described above and resuspended 
(5  ×  106  cells/ml)  in  RPMI-1640  (Grand  Island  Biological  Co.,  Grand  Island,  N.  Y.) 
supplemented with glutamine, penicillin, streptomycin, Hepes buffer, and 10% FCS. Triplicate 
cultures consisting of 0.1 ml of responder cells and 0.1 ml of X-irradiated stimulator cells (2,500 
rads) in round bottom, plastic microtrays were incubated for 96 h  at  37°C  in a  humidified 
atmosphere of 5% CO2 in air. Cultures were harvested (Mash II, Microbiological Associates, 
Walkersville, Md.)  after a  4-h  pulse of tritiated thymidine  (0.5  #Ci  3H-TdR;  6.0  Ci/mM, 
Schwarz/Mann Div. Becton, Dickinson & Co., Orangeburg, N. Y.). 
Statistics.  All results are expressed as the mean PFC response per culture zl: standard error. 
The significance of differences between means was determined by Student's t test. 
Results 
Optimal Conditions for LPS-Induced Adjuvanticity  In  Vitro.  For these studies, we have 
utilized the  LPS  responsive C3H/HeN  mouse  strain  and  the histocompatible, LPS 
nonresponsive  C3H/HeJ  mouse  (33,  34).  In  preliminary experiments,  it  was  found 
that maximum numbers of anti-SRC PFC were obtained with 5  ×  106 spleen cells in 
0.5 ml medium from either C3H/HeN  or C3H/HeJ  mice (Fig. 1). This concentration 
of cells was maintained  throughout  all of the experiments reported herein.  In  these 
studies  we  have  employed  a  Ph-LPS  preparation  which  selectively stimulates  LPS 
responsive mice  (33,  34).  As can  be seen  in  Fig.  1 A,  this preparation  of endotoxin 796  CELL  REQUIREMENTS  FOR  LPS-INDUCED  ADJUVANTICITY 
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Fie..  1.  Titration of LPS-induced adjuvanticity of specific  (antigen dependent)  and polyclonal 
(antigen independent) anti-SRC PFC responses.  Primary spleen cell cultures (5 ×  10  n cells/0.5 ml) 
from either C3H/HeN (responder) or C3H/HeJ (nonresponder) mice were incubated with increas- 
ing concentrations of either: A. Ph-LPS or B. Bu-LPS for 5 d. Control cultures (no LPS) represent 
background anti-SRC PFC responses. I-7, C3H/HeN specific; ~, C3H/HeN polyclonal; ,, C3H/HeJ 
specific; ~1, C3H/HeJ polyclonal. 
enhanced the antibody response of C3H/HeN spleen cell cultures. Concentrations of 
0.1  and  1.0 ~g Ph-LPS were most effective, whereas a  log higher concentration (10 
~g) elicited a polyclonal response (antigen-independent generation of anti-SRC PFC). 
Ph-LPS did not enhance the anti-SRC PFC response or induce a polyclonal response 
in  C3H/HeJ  (nonresponsive)  mouse  spleen  cell  cultures.  In  contrast,  a  Bu-LPS 
preparation, which contains lipid A-associated protein (LAP), elicited both adjuvant 
and  polyclonal  responses  in  C3H/HeJ,  as  well  as  C3H/HeN,  mouse  spleen  cell 
cultures (Fig.  1 B), thus demonstrating that the C3H/HeJ spleen cells were able to 
manifest an adjuvant response when appropriately stimulated. Our results concerning 
polyclonal  activation  by  Bu-LPS  and  by  high  concentrations  of Ph-LPS  were  in 
agreement with previous findings by others (9, 35). 
Using this system as an in vitro model of LPS-induced adjuvanticity, we proceeded 
to  analyze which  cell  or  cells  had  to  be  LPS  responsive  for enhancement  of the 
immune  response  to occur.  Because 0.1  or  1.0 ~g of either LPS preparations  were 
maximally effective, these concentrations were utilized in all subsequent experiments. 
Evidence for Macrophage Requirement in LPS-Induced  Adjuvanticity.  We first examined 
the contribution of adherent cells in potentiation of immune responses. Spleen cells 
from C3H/HeN (responder) mice were fractionated into nonadherent  ((3-10 passed) 
and adherent subpopulations.  The two subpopulations of cells were cultured either 
by themselves or together in the presence and absence of Ph-LPS and the antibody 
responses to SRC assessed.  Table I  shows that in the absence of M~, the antibody 
response of the lymphocytes was minimal. Moreover, Ph-LPS (1.0/zg/culture) failed 
to enhance the PFC response unless M~ were present. J.  R.  MeGHEE  ET  AL. 
TABLE  I 
Macrophage Requirement  for LPS Adjuvanticity 
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LPS added (1.0 #g/culture) 
C3H/HeN  (responder) cell cultures* 
None  Ph-LPS 
Lymphocytes and M~  1,085  +  60:~  1,950  +  100 
Lymphocytes only  62:1:19  81  :lz  25 
M~ only  25:1:11  15  :t:  6 
* Splenic lymphocytes (T  and  B cells;  3  X  106/culture)  and splenic macrophages 
from spleen cell preparations given 1,000 rads of irradiation were cultured alone or 
in  combination  and  incubated  with  SRC  (2  X  106/cuhure)  in  the  presence or 
absence of Ph-LPS. 
~: Anti-SRC PFC determined on day 5 after incubation; mean PFC  +  SE of cultures 
in triplicate/experiment; mean of three experiments. 
To  investigate  the  requirement  for  LPS-responsive  MO  during  LPS-induced 
enhancement of antibody responses, splenic MO from either C3H/HeN  (responder) 
or C3H/HeJ (nonresponder)  mice was cocultivated with splenic lymphocytes (G-10 
passed) from either responder or nonresponder mice. Although C3H/HeN M~l were 
fully functional (Fig.  2 A), the adjuvant response of C3H/HeN lymphocytes was not 
restored by C3H/HeJ M¢I (Fig.  2 B). These results demonstrate that the MO must 
be  LPS responsive to-produce an  adjuvant response.  However, it  is clear that  the 
MO  is  not  the only obligatory LPS-responsive cell  in  this  system because  neither 
C3H/HeN  nor  C3H/HeJ  M~  could  restore  the  adjuvant  response  of C3H/HeJ 
lymphocytes (Fig. 2). Bu-LPS, on the other hand, potentiated immune responses with 
both LPS responsive and nonresponsive cell populations  (Fig.  2)  indicating that all 
the cell populations were functional. 
Evidence for a T-Cell Requirement in LPS-lnduced Adjuvanticity.  The above data strongly 
suggested  that  some  LPS-responsive  cell(s)  other  than  the  macrophage  was  also 
important for LPS potentiation of immune responses in vitro. The following experi- 
ments were carried  out to determine if LPS-sensitive T  cells  were required.  C3H/ 
HeN nude  (nu/nu)  mouse spleen cells  served as the source of T-cell deficient, LPS 
responsive population. Purified splenic T cells (1  ×  106/culture) from either responder 
(C3H/HeN)  or nonresponder  (C3H/HeJ)  mice were added to C3H/HeN  (nu/nu) 
spleen cells and the LPS-induced adjuvant response was measured. From the data 
presented  in  Fig.  3,  it can  be seen  that  T  cells were required  for in  vitro immune 
responses to SRC and that potentiation with Ph-LPS occurred only in the presence 
of C3H/HeN  T  cells.  Although C3H/HeJ  splenic  T  cells could  support  immune 
responses similar to controls, no enhancement by Ph-LPS was observed, indicating 
that LPS responsive T  cells, as well as macrophages, were required for adjuvanticity. 
Bu-LPS (containing LAP) enhanced the anti-SRC PFC responses with either T-cell 
preparation.  No response was observed in LPS-treated cultures in the absence of T 
lymphocytes. In agreement with Parks et al. (36),  a higher concentration of Ph-LPS 
(> 1.0 #g/culture) was required to obtain an immune response in nude mouse spleen 
cell cultures in the absence of added T  cells (data not shown). 
In separate experiments, the requirement for T cells for LPS-mediated enhancement 
of immune responses was examined in cultures of responder nude mouse spleen cells 
immunized with another antigen, TNP-SRC. These studies employed carrier (SRC)- 798  CELL  REQUIREMENTS  FOR  LPS-INDUCED  ADJUVANTICITY 
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FIC.  2.  Requirement  for  LPS  responsive  M~  for  LPS-induced  adjuvanticity.  Adherent  cell 
populations (M~) prepared from irradiated (1,000 rads) spleen cell preparations (5  ×  108 cells/0.5 
ml)  from  responder  (A.  C3H/HeN)  and  nonresponder  (B.  C3H/HeJ)  mice  were  cultured  with 
nonadherent splenic lymphocytes  (3  ×  106 cells/culture)  from either responder (C3H/HeN  F'l) or 
nonresponder (C3H/HeJ m) mice. Cultures were incubated in the presence or absence of either Ph- 
LPS (0.1 or 1.0 #g/culture)  or Bu-LPS (1.0 #g/culture). LPS-induced enhancement of specific anti- 
SRC  PFC  responses was determined  on day  5.  Control cultures  (no LPS)  represent background 
anti-SRC PFC responses. F3, C3H/HeN  T  +  B cells; R, C3H/HeJ  T  +  B cells. 
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FIo.  3.  Requirement  for LPS  responsive T  cells  for LPS-induced  adjuvanticity.  C3H/HeN  (re- 
sponder) nude mouse spleen cells (5  X  106 culture) were cultured alone (no T  cells ~1) or together 
with splenic T  cells (1  ×  106/cuhure) from either responder (C3H/HeN F-I) or nonresponder (C3H/ 
HeJ a)  mice. Cultures were incubated in the presence or absence of either Ph-LPS (0.1  or  1.0 #g/ 
culture)  or Bu-LPS  (0.1  or  1.0 #g/culture).  LPS-induced  enhancement of specific anti-SRC  PFC 
responses was determined on day 5. Control cultures (no LPS) represent background anti-SRC PFC 
responses. F-l, C3H/HeN T  cells; R, C3H/HeJ  T  cells; ~!, no T  cells. 2;5oo 
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Fxo.  4.  Titration  of LPS-induced augmentation  of specific (antigen-dependent) and  polyclonal 
(antigen-independent) anti-TNP  PFC  responses. Spleen ceils (5  ×  10n/0.5  ml)  from C3H/HeN 
(responder) nude mice were cultured  with carrier  (SRC)-primed T cells (1  ×  106/culture) from 
either  responder  (C3H/HeN)  or nonresponder  (C3H/HeJ)  mice. Cultures were incubated  with 
increasing concentrations of either: A. Ph-LPS or B. Bu-LPS for 5 d. Control cultures (no LPS). 
represent background anti-TNP  PFC responses. [7, C3H/HeN T cell: specific; VA, C3H/HeN T cell: 
polyclonal; II, C3H/HeJ T cell: specific; [], C3H/HeJ T cell: polyclonal. 
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primed T  cells and enhancement  of anti-TNP  PFC responses was determined.  Nude 
mouse  spleen  cells  cultured  with  purified  splenic  T  cells  from either  C3H/HeN  or 
C3H/HeJ  mice elicited an immune response to TNP-SRC  (Fig. 4). Optimal doses of 
Ph-LPS  (0.1  and  1.0 btg) induced significant enhancement  of anti-TNP  PFC, and at 
higher doses (10/.tg) nonspecific, polyclonal responses were observed (Fig. 4 A), similar 
to those obtained when SRC was used as antigen  (Fig.  1). As was seen with the anti- 
SRC PFC response (Fig. 3), the specific anti-TNP PFC response of cultures containing 
nonresponsive  (C3H/HeJ)  T  cells was not augmented  with  Ph-LPS.  Potentiation  of 
antibody  responses  occurred  in  all  cases  when  Bu-LPS  was  used  (Fig.  4  B).  These 
results (Figs. 3 and 4) indicate that LPS sensitive T  cells are necessary for the adjuvant 
effect  of LPS.  Taken  together,  these  data  would  suggest  that  both  LPS-responsive 
MO and T  cells are required  for LPS-induced adjuvanticity. 
Responder  T  Cells and  Macrophages Control LPS-Induced Augmentation of B-Cell Re- 
sponses.  To determine if LPS responsive B cells were also required  for adjuvanticity, 
we next investigated the ability of LPS-responsive T  cells and MO to support Ph-LPS 
enhanced anti-TNP PFC responses in cultures containing either purified LPS respon- 
sive  or  nonresponsive  B  cells.  Purified  populations  of B  or  T  lymphocytes  were 
prepared  by  fractionation  of  either  C3H/HeN  or  C3H/HeJ  glass  wool  passed, 
nonadherent  spleen cells on nylon wool columns. The B- and T-lymphocyte subpop- 
ulations  were  subsequently  treated  with  either  anti-theta  or  anti-immunoglobulin 
sera,  respectively,  and  complement.  Adherent  cells  were  obtained  from  C3H/HeN 
nude  spleen  cells.  Each  cell  population  was  added  individually  to culture  and  the 
adjuvant  response  of  the  cell  mixture  was  determined.  Responder  T  cells  plus 800  CELL REQUIREMENTS  FOR  LPS-INDUCED  ADJUVANTICITY 
TABLE II 
Requirement  for T Cells and Macrophages  for LPS Adjuvanticity in Both Responder  and Nonresponder B 
Cells* 
Group 
Cell source (C3H)  LPS added to culture (1.0 ~tg/culture) 
B cell  T cell  MO~  None  Ph-LPS  Bu-LPS 
1  HeN  HeN  HeN nude  920 +  60§  1,505 ±  75  1,680 +  92 
2  HeJ  HeN  HeN nude  695 ±  35  1,035 :i: 46  1,210:1:85 
3  HeN  HeJ  HeN nude  1,101:1:60  1,185 +  84  1,440 ±  60 
4  He.]"  HeJ  HeN nude  806 -  85  747 ±  62  1,368 ±  49 
5  HeN  None  HeN nude  22 ±  10  40 ±  20  35 ±  18 
6  HeJ  None  HeN nude  2 ±  2  4 +  2  3 ±  3 
7  None  None  HeN nude  22 ±  11  15 +  5  20 +  9 
* Purified  splenic T or B cells (1  ×  106/cuhure) from either C3H/HeN or C3H/HeJ  mice previously 
injected (1 wk earlier) i.v. with SRC (0.1 ml of 0.01% suspension). 
:~ Splenic macrophages from C3H/HeN nu/nu spleen cell preparations given 1,000 rads of irradiation and 
plated at equivalent  (5  ×  106 cells/0.5  ml) concentration  and incubated with TNP-SRC  (2  X  106/ 
culture) with or without Ph- or Bu-LPS. 
§ Anti-TNP PFC  determined  on  day 5 after incubation;  mean  PFC  +  SE of cultures  in  triplicate/ 
experiment; mean of three experiments. 
responder M~  supported Ph-LPS adjuvant responses to TNP-SRC  when B cells were 
derived from either responder or nonresponder mice (Table II; groups 1 and 2). When 
T  cells were  derived from  C3H/HeJ  mice and  incubated  with  responder  M~  and 
either responder or nonresponder  B  cells  (groups  3  and  4),  no  enhancement  in  the 
immune  response was  observed, again  emphasizing  the  need  for  LPS  responsive T 
lymphocytes. Cultures of B  cells and/or MO  alone did not respond to antigen either 
in the presence or absence of LPS. 
Another series of experiments were carried out with B cells from LPS nonresponder 
nude  mice  (C57BL/10ScN) 3  as  an  alternate  source  of  B  cells.  Spleen  cells  from 
C57BL/10Sn  mice were used as the histocompatible, LPS responsive cell populations. 
Again, each  cell population was  prepared and  added individually to culture.  Mac- 
rophage-depleted B  cells were  prepared by passage of nu/nu  spleen cells over glass 
wool columns. T  cells were prepared by fraetionation of spleen cells on glass wool and 
nylon wool columns and adherent cells served as the source of M~. 
LPS  nonresponsive  (C57BL/10ScN)  B  cells exhibited an  adjuvant  response  after 
incubation  with  LPS  responsive  (C57BL/10Sn)  T  cells  and  M~  (Fig.  5),  again 
demonstrating  that  LPS  responsive  B  cells were  not  essential  for  adjuvanticity in 
vitro. In contrast, no Ph-LPS augmentation of the immune response of nonresponder 
B  cells occurred when  either T  cells or MO  were  derived from  nonresponder  mice 
(C57BL/10SEN), confirming that T  cells and M~  must be LPS responsive to produce 
an adjuvant response. 
As a  control, the same experiment was performed using splenic B  cells from C3H/ 
HeN  (responder)  nude  mice.  These  LPS  responsive  B  cells exhibited  an  adjuvant 
response  in  the  presence  of responder T  cells and  M~,  but  not  in  the  presence of 
nonresponder T  cells and MIZI (Fig. 6). A  slight enhancement in the immune response 
occurred  when  C3H/HeJ  T  cells and  responder  M~  were  tested.  All cell cultures 
were  capable  of exhibiting  LPS-induced  potentiation  of anti-TNP  PFC  responses, 
3 Vogel, S. N., C. T. Hansen, and D. L. Rosenstreich. 1979.J. Immunol. In press. 801 
2,,000: 
1,500 
None 
u. 1,000 
a. 
z  I- 
50O 
J.  R.  McGHEE  ET  AL. 
Bu-LPS 
Ph-LPS 
i 
LPS (1.0 ~g/Culture) 
FIo.  5.  Requirement for LPS responsive T  cells and Mg3 for LPS-induced adjuvanticity. Splenic 
B cells  (1  ×  10n/culture) from LPS nonresponder (C57BL/10ScN) nude mice were cultured with 
splenic T  cells (1  ×  106/culture) and adherent cells  (prepared from 5  X  106 spleen ceUs/0.5 ml 
given 1,000 rads) derived from either responder (C57BL/10Sn) or nonresponder (C57BL/10ScN) 
mice. Cultures were incubated for 5 d in the presence or absence of either Ph-LPS or Bu-LPS (1.0 
#g/culture).  Control  cultures  (no  LPS)  represent  background  anti-TNP  PFC  responses.  I-I, 
C57BL/10Sn T  cells  +  M~; VA, C57BL/10ScN T  cells  +  C57BL/10Sn M~; l,  C57BL/10Sn T 
cells +  C57BL/10ScN MO; m, C57BL/10ScN T cells  +  MO. 
because Bu-LPS elicited enhanced responses with all cell combinations (Figs.  5 and 
6).  These  studies  demonstrate  that  responder  T  cells  and  M~  can  support  LPS 
potentiation  of the  immune  response  regardless  of the  LPS  sensitivity  of the  B 
lymphocyte. 
To insure that these observations were not due, in part, to an allogeneic effect, we 
have examined the MLR of each strain  employed. As  reported earlier  (33), C3H/ 
HeN  and  C3H/HeJ  mice  were  completely histocompatible  (Table  III).  We  have 
extended these observations to C3H/HeN nu/nu and nu/+  mice, and as can be seen 
in Table III, no MLR was observed with any combination of C3H strains. Table IV 
lists  the results of similar studies with C57BL/10Sn  (responder) and C57BL/10ScN 
(nonresponder) mice. The C57BL substrains employed in these studies exhibited no 
significant MLR. Thus, it is unlikely that the adjuvant results obtained in this study 
were due to an allogeneic effect. 
Discussion 
The  results  of this  study  clearly  indicate  that  both  T  lymphocytes  and  MO 
contribute to LPS-induced potentiation of the antibody response in vitro. Therefore, 
it is not surprising that earlier studies which focused on either of these cells, observed 
that one or the other of these cell types was important in adjuvanticity (9,  12-15,  19, 
20).  Thus, only by careful separation of cells from either LPS responder or nonre- 802  CELL  REQUIREMENTS  FOR  LPS-INDUCED  ADJUVANTICITY 
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Fro.  6.  Requirement for LPS responsive T  cells and M~ for LPS-induced adjuvanticity. Splenic 
B cells (1  x  108 culture) from LPS responder (C3H/HeN) nude mice were cultured with splenic T 
cells  (1  ×  106/culture) and adherent cells  (prepared from 5  X  108 spleen cells/0.5 ml given 1,000 
rads) derived from either responder (C3H/HeN) or nonresponder (C3H/HeJ) mice. Cultures were 
incubated for 5 d in the presence or absence of either Ph-LPS or Bu-LPS (1.0/1g/culture). Control 
cultures (no LPS)  represent background anti-TNP PFC responses.  V-I, C3H/HeN T  cells  +  M~; 
I~, C3H/HeJ T  cells  +  C3H/HeN M~; II, C3H/HeN T cells  +  C3H/HeJ M~; Ira, C3H/HeJ T 
cells  +  M~. 
TABL~  III 
Absence of Mixed Lymphocyte Reactions between C3H/HeN Nude and C3H/ 
HeN and C3H/HeJ Mice 
Responder strain  Stimulator strain*  MLR reaction 
HeJ  HeN  1,104 -+  61:~ 
HeJ  HeN (nude)  874  _  76 
HeJ  HeJ  592  +  29 
He.]  C57BL/6J  7,682  +  603 
HeJ  HeN (Nu/+)  609  +  111 
HeN  He..]  705  ±  93 
HeN  HeN (nude)  819  ±  72 
HeN  HeN  1,182  --.  230 
HeN  C57BL/6J  4,646  ---  661 
HeN  HeN (Nu/+)  728 __.  48 
C57BL/6J  HeN  10,109  ±  357 
C57BL/6J  HeN (nude)  8,876  ±  206 
C57BL/6J  HeJ  13,115  ±  1,287 
C57BL/6J  C57BL/6J  1,380  ±  77 
C57BL/6J  HeN (Nu/+)  681  ±  52 
* Stimulator cells in MLR received 2,500 rads of irradiation. 
:~ CPM aH-TdR incorporated by 5  X  105 cells (4-d culture). 
sponder  mice and  examination  of their ability to  support  adjuvant  responses,  could 
we evaluate  their contribution  to enhancement  of immune  responses in vitro. 
From  the data  presented  in  Figs.  2  and  5,  it  is clear that  the MO  is an  important 
contributor  to LPS-induced  adjuvanticity, as had been suggested earlier by Hoffmann J.  R.  McGHEE ET AL. 
TABLE IV 
Absence of Mixed Lymphocyte Reactions between C57BL/ lOScN Nude and 
C57BL/ IOScN  and C57BL/ lOSn Mice 
Responder strain  Stimulator  strain*  MLR reaction 
C57BL t 10ScN 
C57BL / 10ScN 
C57BL / 10SEN 
C57BL / 10ScN 
C57BL/10Sn 
C57BL / 10Sn 
C57BL / 10Sn 
C57BL / 10Sn 
C3H/HeN 
C3H/HeN 
C3H/HeN 
C3H/HeN 
C57BL/10Sn  717:1:  68~: 
C57BL/10ScN (Nu/Nu)  914 +  76 
C57BL/10ScN  1,102 +  201 
C3H/HeN  8,907 "4-  406 
C57BL/10Sn  1,029 :t:  114 
C57BL/10ScN (Nu/Nu)  776 +  61 
C57BL/10ScN  911  :t:  116 
C3H/HeN  11,209 :l:  782 
C57BL/10Sn  13,208 :t:  942 
C57BL/10ScN (Nu/Nu)  11,371 :t:  806 
C57BL/10ScN  13,862 :t:  1,124 
C3H/HeN  1,182:1:  230 
* Stimulator cells in MLR received 2,500 rads of irradiation. 
CPM 3H-TdR incorporated by 5 X 10  s cells (4-d culture). 
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and  colleagues  (9).  Nevertheless,  the  MO  alone was  incapable  of potentiating  the 
immune response unless responder lymphocytes were present. Thus, the accessory cells 
(the MO) cannot totally account for the enhancement of responses by endotoxin. The 
above mentioned studies which pointed to the MO as the most important cell type 
for LPS potentiation of immune responses could have utilized Me) preparations with 
contaminating  LPS  responsive  T  cells  (9).  In  this  study,  we  have  overcome  this 
problem by obtaining M~  from T-cell-deficient nude mice. 
In  support  of earlier  work  (13-15),  our  data  clearly  suggests  that  the  T  cell  is 
important  in  LPS  potentiation  of immune  responses.  It  is  likely that  endotoxin  is 
acting on the T-helper cell population because T  cells derived from carrier-primed, 
responder  mouse  spleen  enhanced  immune  responsiveness  to  the  hapten,  TNP. 
Similarly treated splenic T  cells from C3H/HeJ mice supported immune responses in 
the presence of Ph-LPS and adjuvant  responses in  the presence of Bu-LPS,  further 
suggesting that LPS acts on the T-helper cell population. Although the T  cell itself is 
not generally regarded as an LPS-responsive cell, there is evidence that this may not 
be true. Koenig et al. (37)  showed that gradient-purified T  cells responded to LPS as 
manifested  by  differentiation  in  vitro.  Furthermore,  Narayanan  and  Sundharadas 
(38)  found  that  LPS  would  augment  the  development  of cytotoxic T  cells  in  the 
absence of macrophages. Therefore, it is certainly possible that LPS is acting directly 
on the T  cell to induce its adjuvant effect. However, it must be emphasized that both 
LPS  responsive  M~  and  T-helper  cells  are  important  in  potentiation  of immune 
responses. 
The fact that an LPS responsive B cell was not required for adjuvanticity in vitro 
was somewhat surprising.  Because of the failure of C3H/HeJ spleen cells to exhibit 
an adjuvant effect and because C3H/HeJ mice were thought to possess an isolated B- 
cell defect, previous workers  (3-5)  felt that  adjuvanticity was mediated by a  direct 
effect of LPS on B cells. However, subsequent studies showing the maerophage (39) 
and  T-cell  (37)  defects  in  these  mice  make  the  former hypothesis  untenable.  The 
findings  of Hoffmann  et  al.  (9),  which  showed  that  C3H/HeJ  spleen  cells  could 
exhibit an adjuvant response in vitro in the presence of tumor necrosis factor (TNF)- 804  CELL REQUIREMENTS  FOR  LPS-INDUCED ADJUVANTICITY 
rich serum are consistent with the idea that LPS responsive B cells are not essential 
for this effect. Our findings confirm and extend those of Hoffmann and coworkers. 
The apparent separation of LPS adjuvanticity from mitogenicity in responder mice 
achieved by Poe and Michael (40) also lends support to the conclusion that enhance- 
ment of immune responses can occur by LPS action on lymphoid elements other than 
the B cell. In this regard, Frank and coworkers (41) utilized a detoxified, polysaccha- 
ride-rich  fraction  from  Serratia  LPS  which  could  enhance  immune  responses  in 
experimental cultures very similar to those reported here, although the fraction was 
not mitogenic for B cells. These studies taken together would suggest that LPS can be 
modified to allow adjuvant responses in the absence of a B-cell mitogenic effect. Our 
own results also suggest that with low concentrations of Ph-LPS (0.1 or 1.0 #g), good 
adjuvant responses can be obtained only in the presence of T  cells.  At these concen- 
trations Ph-LPS, immunized spleen cell cultures from nude mice do not elicit normal 
immune responses to antigen. However, addition of T  cells to these cultures results in 
normal and endotoxin-induced enhanced immune responses. These studies indirectly 
argue for other mechanisms for LPS adjuvanticity, and our own work reported here, 
clearly shows that potentiation of immune responses by LPS can be mediated by the 
T  lymphocyte and the M~. 
The mechanisms whereby endotoxin potentiates immune responses via T  cells and 
M~  remain unclear. It is well known that LPS can enhance the production of M~- 
derived  mediators  such  as  lymphocyte-activating factor  (LAF)  which  could  then 
enhance  T-helper cell  production  (42)  with  subsequent  enhancement  of antibody 
responses (21). The action of LPS on the T  cell is not as clear. One possibility is that 
by enhancing differentiation of T  cells,  as shown  by Koenig et  al.  (37),  LPS may 
increase the pool of helper cells and thereby augment antibody production. Alterna- 
tively, LPS may induce the production of some T-cell-derived helper factor. Although 
such  a  mechanism  has  never  been  demonstrated  for  LPS,  it  is  interesting  that 
Hoffmann et al. (9) can substitute TNF-rich serum for both M~ and T  cells.  Because 
we have shown that T  cells are also required for adjuvanticity, it is likely that TNF- 
rich serum contains both a  T-cell product as well as a  M~  product. This is likely 
because TNF is produced in response to a  challenge that  involves T  cells  (Bacillus 
Calmette-Guerin treatment). One would predict then, that nonresponder B cells could 
be induced to exhibit an adjuvant-like response in the presence of separately added, 
LPS-induced T  cell and/or M~-derived factors. Studies are currently underway in 
our laboratory to investigate this possibility. 
Summary 
By employing primary cultures  of purified spleen  cells  from  lipopolysaccharide 
(LPS) responder (C3H/HeN or C57BL/10Sn) or nonresponder (C3H/HeJ or C57BL/ 
10ScN) mice incubated with particulate antigen and LPS prepared by phenol-water 
extraction  (Ph),  we  have  presented  evidence  that  both  T  cells  and  macrophages 
(M~)  are  required  for LPS-induced adjuvanticity.  First,  M~  derived from C3H/ 
HeN spleen cells, when mixed with responder, C3H/HeN lymphocytes and Ph-LPS, 
elicited enhanced antibody responses to sheep erythrocyte (SRC)  antigen,  whereas 
lymphocytes  from  the  nonresponder,  C3H/HeJ  mouse  strain  did  not  evoke  this 
response.  Similarly,  purified T  cells  from  C3H/HeN  spleens,  when  cultured  with 
responder,  nu/nu  spleen  cells,  and  Ph-LPS  yielded  enhanced  anti-TNP  PFC  re- J.  R.  MeGHEE  ET AL.  805 
sponses; whereas, C3H/HeJ  T  cells did not potentiate immune responses when mixed 
with optimal concentrations  of Ph-LPS.  LPS prepared  by butanol-water  extraction 
elicited  significant  adjuvant  effects  with  all  cell  combinations.  Finally,  purified 
responder T  cells and MO enabled either responder or nonresponder B cells to elicit 
LPS  potentiation.  These  data  indicate  that  T  cells  and  MO  are  controlling  LPS- 
induced augmentation of B-cell responses. 
We thank Doctors J. T. Hoffeld, J. J. Oppenheim, R. N. Moore, and S. M. Wahl for critical 
assessment  of this work and Mrs. Carrie McGahey for editorial assistance. 
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